Phase II/III trial studies SHR-1701 with BP-102 and XELOX in first-line metastatic colorectal cancer July 19, 2021
Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA July 19, 2021